🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single group study to determine the pharmacokinetic ...
Status
Completed
Location
The Ottawa Hospital
Start Date
2014-01
Trial ID
NCT02034838
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
The purpose of this study is to compare the anti-HIV efficacy, safety and e...
Status
Completed
Location
Local Institution
Start Date
2004-05
Trial ID
NCT00135395
Treatments Being Tested
MODERATO is a phase III, open-label, randomized, multicenter, non-inferiori...
Status
Unknown
Location
Hôpital de jour, Service des maladies infectieuses, CHU Sourô Sanou
Start Date
2020-09-21
Trial ID
NCT04022967
This study will evaluate how safe and tolerable a combination of taking thr...
Status
Terminated
Location
Fenway Health
Start Date
2012-02
Trial ID
NCT01602822
Treatments Being Tested
The goal of this study is to evaluate the ability of a natural supplement (...
Status
Completed
Location
Clinical Research Center, UCSF
Start Date
2013-01
Trial ID
NCT01759875
A selection study in treatment naive HIV patients to compare the virologic ...
Status
Completed
Location
International Medical Center of Japan
Start Date
2005-09
Trial ID
NCT00280969
Treatments Being Tested
The lack of data relating to the DDI between ATV and RIF is a major limitat...
Status
Completed
Location
Desmond Tutu HIV Foundation
Start Date
2019-09-02
Trial ID
NCT03923231
Treatments Being Tested
The main objective of this study is to evaluate at 96 weeks the safety with...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-01
Trial ID
NCT06338826
This is a pilot study to examine if the novel treatment regimen maraviroc p...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-03
Trial ID
NCT00827112